These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30472113)

  • 21. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice.
    Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.
    Weiss S; Nosten-Bertrand M; McIntosh JM; Giros B; Martres MP
    Neuropsychopharmacology; 2007 Dec; 32(12):2465-78. PubMed ID: 17375139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of brain α
    Luhrs L; Manlapaz C; Kedzie K; Rao S; Cabrera-Ghayouri S; Donello J; Gil D
    Neuroscience; 2016 Dec; 339():608-621. PubMed ID: 27751959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats
    Kurzina N; Belskaya A; Gromova A; Ignashchenkova A; Gainetdinov RR; Volnova A
    Front Psychiatry; 2022; 13():851296. PubMed ID: 35401264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G; Krapacher F; Ferreras S; Quassollo G; Mari MM; Pisano MV; Montemerlo A; Rubianes MD; Bregonzio C; Arias C; Paglini MG
    Exp Neurol; 2021 Dec; 346():113866. PubMed ID: 34537209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons.
    Berlanga ML; Price DL; Phung BS; Giuly R; Terada M; Yamada N; Cyr M; Caron MG; Laakso A; Martone ME; Ellisman MH
    Brain Res; 2011 May; 1390():41-9. PubMed ID: 21439946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice.
    Carpenter AC; Saborido TP; Stanwood GD
    Dev Neurosci; 2012; 34(2-3):250-7. PubMed ID: 22572477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
    Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
    Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
    Chen R; Tilley MR; Wei H; Zhou F; Zhou FM; Ching S; Quan N; Stephens RL; Hill ER; Nottoli T; Han DD; Gu HH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9333-8. PubMed ID: 16754872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.
    Isingrini E; Perret L; Rainer Q; Sagueby S; Moquin L; Gratton A; Giros B
    J Psychiatry Neurosci; 2016 Apr; 41(3):169-81. PubMed ID: 26505143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study.
    Sanna F; Bratzu J; Serra MP; Leo D; Quartu M; Boi M; Espinoza S; Gainetdinov RR; Melis MR; Argiolas A
    Front Behav Neurosci; 2020; 14():58. PubMed ID: 32372926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females.
    Pardo M; Martin M; Gainetdinov RR; Mash DC; Izenwasser S
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased ethanol preference and consumption in dopamine transporter female knock-out mice.
    Savelieva KV; Caudle WM; Findlay GS; Caron MG; Miller GW
    Alcohol Clin Exp Res; 2002 Jun; 26(6):758-64. PubMed ID: 12068242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD and the dopamine transporter: are there reasons to pay attention?
    Mazei-Robinson MS; Blakely RD
    Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
    Morice E; Denis C; Giros B; Nosten-Bertrand M
    Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):623-37. PubMed ID: 14624807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.